Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 16,349 | 8,846 | 7,363 | 1,078 | 6,998 |
| Gross Profit | 16,349 | 8,846 | 7,363 | 1,078 | 6,998 |
| Operating Expenses | 35,091 | 32,326 | 33,407 | 33,886 | 34,494 |
| Operating Income | -18,742 | -23,480 | -26,044 | -32,808 | -27,496 |
| Other Income | 53 | 27 | 28 | 107 | 660 |
| Pre-tax Income | -18,689 | -23,453 | -26,016 | -32,701 | -26,836 |
| Net Income Continuous | -18,689 | -23,453 | -26,016 | -32,701 | -26,836 |
| Net Income | $-18,689 | $-23,453 | $-26,016 | $-32,701 | $-26,836 |
| EPS Basic Total Ops | -9.91 | -13.21 | -15.02 | -18.92 | -15.62 |
| EPS Basic Continuous Ops | -9.91 | -13.36 | -14.92 | -18.92 | -15.71 |
| EPS Diluted Total Ops | -9.91 | -13.21 | -15.02 | -18.92 | -15.62 |
| EPS Diluted Continuous Ops | -9.91 | -13.36 | -14.92 | -18.92 | -15.71 |
| EBITDA(a) | $-16,276 | $-21,009 | $-23,545 | $-30,355 | $-25,106 |